Skip to content
Home/Companies/Healthcare/Minka Therapeutics

Minka Therapeutics

Healthcare·France·Exited 2022·Held 6yr
Entry
2016
Hold
6yr
Exit
2022

Who owns Minka Therapeutics?

Minka Therapeutics was owned by Karista through CapDecisif 3 (2013 vintage) from 2016 to 2022, exited via MBO.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Karista
Investor
Karista
CapDecisif 3 · 2013 · VC

Key facts

HQFrance
SectorHealthcare
Exit Type
MBO
Buyer
MOIC
–
Exit Year
2022

More from CapDecisif 3

Other portfolio companies in the same fund.

Acticor Biotech
Exited 2025
BiotechFrance· 2017
Endodiag
Endodiag
Active
BiotechFrance· 2017
PayinTech
Active
FinancialsFrance· 2017
PulseSight Therapeutics
Exited 2019
HealthcareFrance· 2017
to
Actvt
Active
SoftwareFrance· 2016
E(ye)Brain
E(ye)Brain
Active
HealthcareFrance· 2016

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Minka Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Minka Therapeutics?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Minka Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue